ArticleOncology letters2018

miR-27a in serum acts as biomarker for prostate cancer detection and promotes cell proliferation by targeting Sprouty2.

Weiyin Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.